News & Media :: Vedanta Biosciences, Inc.

Sep 16, 2020

Vedanta Biosciences Announces the Appointment of Jeffrey Silber, M.D. as Chief Medical Officer

Recent News

Aug 5, 2020

Racing the clock to stop drug-resistant superbugs

Aug 4, 2020

Increased diversity of gut microbiota during active oral immunotherapy in peanut‐allergic adults

Jul 8, 2020

Microbiome therapeutics and patent protection

Jun 9, 2020

Vedanta Biosciences Announces Positive Topline Data from Two Phase 1 Studies of VE202, a Rationally Defined Bacterial Consortium Being Advanced for Inflammatory Bowel Diseases (IBD)

View All News View All Press Releases